ResearcherHacettepe UniversityActive in the last 2 years
Sema Çalış
Matched on ORCID iD 0000-0003-1778-5142; OpenAlex author ID A5061510247.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 2 (first author 0, last author 1)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 3
2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper
Papers 2
- Gemcitabine-loaded chitosan nanoparticles enhanced apoptotic and ferroptotic response of gemcitabine treatment alone in the pancreatic cancer cells in vitro. Co-author DOI 10.1007/s00210-024-03193-6↗
- Effective targeting of gemcitabine to pancreatic cancer through PEG-cored Flt-1 antibody-conjugated dendrimers. Last author DOI 10.1016/j.ijpharm.2016.12.009↗
Closest collaborators
The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Kıvılcım Öztürk Atar · 2 shared papers, 2017–2024
- Paper Gemcitabine-loaded chitosan nanoparticles enhanced apoptotic and ferroptotic response of gemcitabine treatment alone in… DOI 10.1007/s00210-024-03193-6↗
- Paper Effective targeting of gemcitabine to pancreatic cancer through PEG-cored Flt-1 antibody-conjugated dendrimers. DOI 10.1016/j.ijpharm.2016.12.009↗
- Nuriye Nuray Ulusu · 1 shared paper, 2024
- Duygu Aydemir · 1 shared paper, 2024
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.